1H-pyrazol-1-amine

Compound number
MolPort-027-834-647
CAS number
3994-46-5
IUPAC
1H-pyrazol-1-amine
IUPAC traditional
pyrazol-1-amine
SMILES
Nn1cccn1
InChI key
NYIGEYYREVRXES-UHFFFAOYSA-N
Molecular formula
Molecular weight
83.094
Solubility
not available

Marketplace Offers

BIONET - Key Organics Ltd.

Direct S&H to USA:
80.00 USD
Catalog
Building blocks
Ships out
10 business days
Purity
95%
Last updated
this week
In warehouse
10.00 g

Supplier Catalogue Data

Pack size Ships out Price Quantity
500 mg August 25, 2022 337.00 USD
Add to Cart Buy
1 g August 25, 2022 422.00 USD
Add to Cart Buy
5 g August 25, 2022 1264.00 USD
Add to Cart Buy

BLD Pharmatech (made-to-order)

Direct S&H to USA:
90.00 USD
Catalog
Building blocks
Ships out
25 business days
Purity
95+%
Last updated
last week
In warehouse
Unverified

Supplier Catalogue Data

Pack size Ships out Price Quantity
1 g September 15, 2022 287.00 USD
Add to Cart Buy

AK Scientific (made-to-order)

Direct S&H to USA:
20.00 USD
Catalog
Building blocks
Ships out
20 business days
Purity
95.00%
Last updated
> 3 months ago
In warehouse
Unverified

Supplier Catalogue Data

Pack size Ships out Price Quantity
1 g September 8, 2022 335.00 USD
Add to Cart Buy

Get your compounds in the right format

Molport Reweighting and Reformatting Services

More Information

Compound identifiers

Compound number
MolPort-027-834-647
CAS number
3994-46-5

Names, Synonyms and 3rd Party Identifiers

Name
1H-Pyrazol-1-amine
MFCD13190793

InChI

InChI
1/C3H5N3/c4-6-3-1-2-5-6/h1-3H,4H2
InChI key
NYIGEYYREVRXES-UHFFFAOYSA-N

Formula

Molecular formula
C3H5N3
Molecular weight
83.094

Molport Guarantee

When you purchase products through the Molport website from any seller other than Molport itself, you will be protected by the Molport Guarantee. If you purchase products from Molport itself, this Molport Guarantee will not apply, and your remedies will be governed by the Molport Terms of Sale and Supply.

We use cookies to improve your experience on our websites and for advertising. By clicking "Accept All", you consent to our use of cookies. Learn more.

Feedback